Fluorimax 5000 Sensitive

1.1% Sodium Fluoride With 5% Potassium Nitrate Toothpaste


Elevate Oral Care
Human Prescription Drug
NDC 57511-0503
Fluorimax 5000 Sensitive also known as 1.1% Sodium Fluoride With 5% Potassium Nitrate Toothpaste is a human prescription drug labeled by 'Elevate Oral Care'. National Drug Code (NDC) number for Fluorimax 5000 Sensitive is 57511-0503. This drug is available in dosage form of Paste, Dentifrice. The names of the active, medicinal ingredients in Fluorimax 5000 Sensitive drug includes Potassium Nitrate - 5 g/100g Sodium Fluoride - 1.1 g/100g . The currest status of Fluorimax 5000 Sensitive drug is Active.

Drug Information:

Drug NDC: 57511-0503
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Fluorimax 5000 Sensitive
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: 1.1% Sodium Fluoride With 5% Potassium Nitrate Toothpaste
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Elevate Oral Care
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Paste, Dentifrice
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:POTASSIUM NITRATE - 5 g/100g
SODIUM FLUORIDE - 1.1 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 15 Jun, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 20 Jan, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Elevate Oral Care
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:637365
2603764
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:RU45X2JN0Z
8ZYQ1474W7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
57511-0503-22 TUBE in 1 BOX (57511-0503-2) / 96 g in 1 TUBE (57511-0503-1)15 Jun, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Product Elements:

Fluorimax 5000 sensitive 1.1% sodium fluoride with 5% potassium nitrate toothpaste saccharin sodium fluoride fluoride ion glycerin hydrated silica xylitol potassium phosphate, monobasic potassium nitrate nitrate ion water sorbitol

Warnings:

Warnings warnings: do not swallow. keep out of reach of children under 12 yeaars of age. read all instructions and prescribing information before using this product. don't freeze or expose to extreme heat. note: sensitive teeth may indicate a serious problem that may need prompt care by a dentist. see your dentist if the problem persists or worsens. do not use this product longer than 4 weeks unless recommended by a dentist or physician.

Package Label Principal Display Panel:

Package label and instructions for use primary package label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.